Abstract PR002: Surveillance-detected pancreatic cancers: Updated report from the PRECEDE Consortium
The Pancreatic Cancer Early Detection (PRECEDE) Consortium is a multinational prospective longitudinal cohort study of participants with elevated heritable risk for pancreatic adenocarcinoma, with an overarching goal to increase survival of PC by driving early detection.